Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

LeMaitre Vascular Inc

+ Add to Watchlist

LMAT:US

8.6000 USD 0.0300 0.35%

As of 20:10:00 ET on 04/24/2015.

Snapshot for LeMaitre Vascular Inc (LMAT)

Open: 8.5200 Day's Range: 8.5000 - 8.6600 Volume: 36,273
Previous Close: 8.5700 52wk Range: 6.4800 - 8.6600 1-Yr Rtn: +9.57%

Stock Chart for LMAT

No chart data available.
  • LMAT:US 8.6000
  • 1D
  • 1M
  • 1Y
8.5700
Interactive LMAT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LMAT

Current P/E Ratio (ttm) 32.8872
Estimated P/E(12/2015) 32.8244
Relative P/E vs. SPX 1.7596
Earnings Per Share (USD) (ttm) 0.2615
Est. EPS (USD) (12/2015) 0.2620
Est. PEG Ratio -
Market Cap (M USD) 150.59
Shares Outstanding (M) 17.51
30 Day Average Volume 30,922
Price/Book (mrq) 2.1903
Price/Sale (ttm) 2.0064
Dividend Indicated Gross Yield 1.86%
Cash Dividend (USD) 0.0400
Dividend Ex-Date 03/18/2015
5 Year Dividend Growth -
Next Earnings Announcement 04/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LMAT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LMAT

LeMaitre Vascular, Inc. manufactures medical devices for vascular surgeons and interventionists. The Company develops, produces, and markets disposable and implantable devices for the treatment of peripheral vascular disease, such as stent grafts, anastomotic clips, valvulotomes, radiopaque marking tape, shunts, and embolectomy catheters.

George W LemaitreChairman/CEODavid B RobertsPresident
Joseph P Pellegrino JrChief Financial OfficerPeter R GebauerPresident:Intl Operations
More Company Profile & Key Executives for LMAT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil